台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

國嘉製藥工業股份有限公司幼獅三廠 臺中市大甲區日南里工十路2號 (22596980) - cetylpyridinium chloride - 錠劑 - cetylpyridinium chloride (8404601310) 2mg - cetylpyridinium - 咽喉痛及發炎之緩解。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 台北市敦化南路二段２１６號１５樓 (12350071) - glucose monohydrate;;calcium chloride dihydrate;;glucose;;magnesium chloride (hexahydrate);;l-threonine;;l-alanine;;l-isoleucine;;l-leucine;;lysine l-;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-serine;;l-methionine;;l-valine;;l-phenylalanine;;l-histidine;;l-proline;;l-tryptophan;;potassium chloride;;l-arginine;;sodium glycerophosphate 5h2o;;l-tyrosine;;refine soya + olive oil - 靜脈點滴注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; potassium chloride (4012001800) mg; magnesium chloride (hexahydrate) (4012071550) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine l- (4020101302) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; sodium glycerophosphate 5h2o (9200008550) mg; calcium chloride dihydrate (4012000350) mg; glucose (4020000700) mg; glucose monohydrate (4020000760) mg; refine soya + olive oil (9200027040) mg - combinations - 適用於成人及二歲以上孩童在無法或因有禁忌症而不適宜進食或使用口服腸道營養劑時之靜脈營養。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 台北市敦化南路二段２１６號１５樓 (12350071) - potassium chloride;;lysine l-;;l-histidine;;l-arginine;;l-methionine;;l-glycine;;l-serine;;sodium glycerophosphate 5h2o;;l-proline;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-isoleucine;;l-alanine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;l-valine;;l-tyrosine;;l-leucine;;glucose;;calcium chloride;;refine soya + olive oil - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine l- (4020101302) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; l-glycine (4020102401) mg; sodium glycerophosphate 5h2o (9200008550) mg; calcium chloride (4012000300) mg; glucose (4020000700) mg; refine soya + olive oil (9200027040) mg - combinations - 適用於成人及二歲以上孩童在無法或因有禁忌症而不適宜進食或使用口服腸道營養劑時之靜脈營養。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - fish-oil rich in omega-3 acids;;triglycerides medium chain;;soybean oil ( eq to soya bean oil);;olive oil;;glucose monohydrate;;l-phenylalanine;;magnesium sulphate heptahydrate ;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;l-serine;;l-isoleucine;;calcium chloride dehydrate;;l-tyrosine;;l-leucine;;l-threonine;;sodium glycerophosphate;;l-valine;;l-histidine;;l-tryptophan;;potassium chloride;;l-arginine;;l-lysine acetate;;glycine (eq to aminoacetic acid)(eq to glycocoll);;taurine (eq to aminoethyl sulfonic acid );;l-methionine;;zinc sulphate heptahydrate;;l-proline;;l-alanine - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) (= sodium acetate 3.4 mg)mg; calcium chloride dehydrate (4012000362) (= calcium chloride 0.56 mg)mg; potassium chloride (4012001800) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) (= l-lysine 6.6 mg)mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; magnesium sulphate heptahydrate (5612001583) (= magnesium sulphate 1.2 mg)mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate (9200008500) mg; zinc sulphate heptahydrate (9200010643) (= zinc sulphate 12.9 μg)ug; glucose monohydrate (4020000760) (= glucose anhydrous 420 mg)mg; soybean oil ( eq to soya bean oil) (4020001600) refinedmg; fish-oil rich in omega-3 acids (4020003620) mg; triglycerides medium chain (5640001102) mg; olive oil (9600021200) refinedmg - combinations - 靜脈營養輸注，適用於無法由口腔進食或經腸道獲取足夠營養，或禁止由口腔及腸道進食之成年患者及2歲以上兒童。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

醫療財團法人台灣血液基金會 台北市中正區南海路３號３樓 (01010553) - antithrombin iii;;sodium (acetate);;factor ix;;citrate;;heparin;;chloride;;plasma protein;;phosphate - 凍晶乾燥注射劑 - 主成分 () ; factor ix (2012100700) i.u.; heparin (2012400500) 50~140i.u.; antithrombin iii (2012401400) i.u.; sodium (acetate) (4008009600) m.mol/l; chloride (4026000500) m.mol/l; phosphate (4026001400) m.mol/l; citrate (4026003000) m.mol/l; plasma protein (8004000700) <=20 mgmg - blood coagulation factors - 用以治療和預防，因缺乏第九凝血因子而引起之b型血友病相關的出血病症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - dextrose monohydrate;;sodium lactate solution;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;calcium chloride dihydrate;;sodium chloride - 透析用液劑 - sodium lactate solution (4008000980) gm; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; sodium chloride (4012002100) gm; dextrose monohydrate (4020000570) eq.to dextrose anhydrous 22.73 gmgm - isotonic solutions - 腹膜透析

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - sodium chloride;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;sodium lactate solution;;dextrose monohydrate;;calcium chloride dihydrate - 透析用液劑 - sodium lactate solution (4008000980) gm; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; sodium chloride (4012002100) gm; dextrose monohydrate (4020000570) 46.75gm - peritoneal dialytics - 腹膜透析

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - sodium chloride;;sodium lactate solution;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;dextrose (monohydrate) - 透析用液劑 - sodium lactate solution (4008000980) 7.847gm; calcium chloride dihydrate (4012000350) 0.2573gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) 0.1017gm; sodium chloride (4012002100) 5.786gm; dextrose (monohydrate) (4020009570) (15.00g) 16.50gm - peritoneal dialytics - 腹膜透析

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

科進製藥科技股份有限公司 台北市南港區園區街3號14樓之7 (97301657) - sapropterin dihydrochloride - 錠劑 - sapropterin dihydrochloride (9200093610) (eq. to tetrahydrobiopterin dihydrochloride)mg - sapropterin - 1. bh4缺乏導致之高苯丙胺酸血症(hyperphenylalaninemia due to tetrahydrobioterin deficiency)。2. 對本藥物有反應的高苯丙胺酸血症(hyperphenylalaninemia)且併有苯酮尿症(phenylketonuria)者；對本品有反應的定義為投與本品20mg/kg後，血中phe濃度在24小時以內下降可達30%以上者。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

科進製藥科技股份有限公司 台北市南港區園區街3號14樓之7 (97301657) - sapropterin dihydrochloride - 錠劑 - sapropterin dihydrochloride (9200093610) (eq. to tetrahydrobiopterin dihydrochloride)mg - sapropterin - 1. bh4缺乏導致之高苯丙胺酸血症(hyperphenylalaninemia due to tetrahydrobioterin deficiency)。2. 對本藥物有反應的高苯丙胺酸血症(hyperphenylalaninemia)且併有苯酮尿症(phenylketonuria)者；對本品有反應的定義為投與本品20mg/kg後，血中phe濃度在24小時以內下降可達30%以上者。